These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study. Freeman EW, Sondheimer SJ, Rickels K, Albert J. J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350 [Abstract] [Full Text] [Related]
11. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Freeman EW, Sondheimer SJ, Rickels K. Psychopharmacol Bull; 1997 May; 33(2):303-9. PubMed ID: 9230648 [Abstract] [Full Text] [Related]
12. [No effect of spironolactone on bulimia nervosa symptoms]. von Wietersheim J, Müller-Bock V, Rauh S, Danner B, Chrenko K, Bühler G. Psychother Psychosom Med Psychol; 2008 Dec; 58(12):470-4. PubMed ID: 18666040 [Abstract] [Full Text] [Related]
17. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Chan AF, Mortola JF, Wood SH, Yen SS. Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453 [Abstract] [Full Text] [Related]
18. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D. N Engl J Med; 1995 Jun 08; 332(23):1529-34. PubMed ID: 7739706 [Abstract] [Full Text] [Related]